Avadel Pharmaceuticals plc (AVDL)
USD 10.33
(-3.73%)
USD 10.33
(-3.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -132.86 Million | -70.3 Million | -77.31 Million | -48.73 Million | -38.32 Million | -82.71 Million |
| Net Income | -160.27 Million | -137.46 Million | -77.32 Million | 7.02 Million | -33.22 Million | -95.3 Million |
| Depreciation & Amortization | 1.76 Million | 1.49 Million | 815 Thousand | 1.69 Million | 2.48 Million | 7.43 Million |
| Deferred income taxes | -37.54 Million | 26.02 Million | -15.66 Million | -7.43 Million | -6.33 Million | -19.15 Million |
| Stock-based compensation | 15.81 Million | 7.01 Million | 8.87 Million | 2.99 Million | 519 Thousand | 7.85 Million |
| Change in working capital | -2.99 Million | 24.53 Million | 3.69 Million | -8.13 Million | 2.25 Million | -11.71 Million |
| Other non-cash items | 50.37 Million | 8.09 Million | 2.3 Million | -44.88 Million | -4.02 Million | 28.16 Million |
| Investing Cash Flow | -50.09 Million | 79.69 Million | 56.92 Million | -69.72 Million | 38.72 Million | -36.98 Million |
| Investments in PPE | - | -716 Thousand | -26 Thousand | -98 Thousand | -29 Thousand | -20.17 Million |
| Acquisitions | - | -80.41 Million | 16.5 Million | 25.5 Million | 154 Thousand | 20 Million |
| Investment purchases | -237.22 Million | -3.41 Million | -61.76 Million | -131.4 Million | -24.64 Million | -376.31 Million |
| Sales/Maturities of investments | 187.13 Million | 83.82 Million | 102.22 Million | 36.28 Million | 63.24 Million | 359.5 Million |
| Other Investing Activities | -50.09 Million | 80.41 Million | 16.5 Million | 25.5 Million | 38.75 Million | -20 Million |
| Financing Cash Flow | 135.33 Million | 14.54 Million | 263 Thousand | 179.68 Million | -27 Thousand | 112.65 Million |
| Debt repayment | -38.66 Million | -8.65 Million | - | - | - | -143.75 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -27.63 Million |
| Common Stock Issuance | 148.35 Million | 25.31 Million | 263 Thousand | 179.68 Million | 118 Thousand | 3.48 Million |
| Other Financing Activities | 174 Million | -2.12 Million | 263 Thousand | 179.68 Million | -145 Thousand | -3.45 Million |
| Accounts receivables | -10.21 Million | 30 Thousand | 2.79 Million | 8.28 Million | 2.47 Million | 3.45 Million |
| Accounts payables | 1.54 Million | -3.1 Million | 4.23 Million | -2.78 Million | 4.64 Million | -2.03 Million |
| Inventory | -9.53 Million | -30 Thousand | -2.79 Million | -1.35 Million | 1.15 Million | 711 Thousand |
| Other working capital | 15.2 Million | 27.64 Million | -537 Thousand | -12.27 Million | -6.01 Million | -13.84 Million |
| Cash at beginning of period | 73.98 Million | 50.7 Million | 71.72 Million | 9.77 Million | 9.32 Million | 16.56 Million |
| Cash at end of period | 31.16 Million | 73.98 Million | 50.7 Million | 71.72 Million | 9.77 Million | 9.32 Million |
| Capital Expenditure | - | -716 Thousand | -26 Thousand | -98 Thousand | -29 Thousand | -20.17 Million |
| Effect of forex changes on cash | 455 Thousand | -664 Thousand | -896 Thousand | 720 Thousand | 78 Thousand | -201 Thousand |
| Net cash flow / Change in cash | -42.81 Million | 23.27 Million | -21.01 Million | 61.94 Million | 449 Thousand | -7.23 Million |
| Free Cash Flow | -132.86 Million | -71.02 Million | -77.33 Million | -48.83 Million | -38.35 Million | -102.89 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.82 Million | -27.34 Million | -28.78 Million | -160.27 Million | -36.27 Million | -64.43 Million |
| Depreciation & Amortization | 437 Thousand | 541 Thousand | -18 Thousand | 1.76 Million | 595 Thousand | 601 Thousand |
| Deferred income taxes | - | - | -15.93 Million | -37.54 Million | - | 13.12 Million |
| Stock-based compensation | 5.46 Million | 5.38 Million | 3.51 Million | 15.81 Million | 3.12 Million | 7.64 Million |
| Change in working capital | -9.7 Million | -7.57 Million | -4.35 Million | -2.99 Million | -5.61 Million | 10.4 Million |
| Other non-cash items | 26.25 Million | 10.09 Million | 17.54 Million | 50.37 Million | -55 Thousand | 630 Thousand |
| Investing Cash Flow | 10.42 Million | 21.38 Million | 27.92 Million | -50.09 Million | 9.82 Million | -92.9 Million |
| Investments in PPE | -3.05 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -77.51 Million | -97.67 Million | -33.71 Million | -237.22 Million | -90.05 Million | -103.23 Million |
| Sales/Maturities of investments | 87.93 Million | 119.06 Million | 61.63 Million | 187.13 Million | 99.88 Million | 10.32 Million |
| Other Investing Activities | 10.55 Million | 21.38 Million | -1.00 | -50.09 Million | 9.82 Million | -92.9 Million |
| Financing Cash Flow | 667.39 Thousand | 13.19 Million | -21.11 Million | 135.33 Million | 30.46 Million | 91.54 Million |
| Debt repayment | - | - | -21.16 Million | -38.66 Million | -30.2 Million | -40.12 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 667.39 Thousand | 13.19 Million | -1.72 Million | 148.35 Million | 396.58 Thousand | 136.96 Million |
| Other Financing Activities | 723 Thousand | 13.19 Million | 54 Thousand | 174 Million | 30.46 Million | 91.54 Million |
| Accounts receivables | -10.13 Million | -10.6 Million | -5.89 Million | -10.21 Million | -4.46 Million | 351.99 Thousand |
| Accounts payables | -9.15 Million | 7.52 Million | -2.29 Million | 1.54 Million | 1.36 Million | 2 Million |
| Inventory | -994.95 Thousand | -1.26 Million | -4.24 Million | -9.53 Million | -3.84 Million | -1.43 Million |
| Other working capital | 10.58 Million | -3.23 Million | 8.08 Million | 15.2 Million | 1.32 Million | 9.49 Million |
| Cash at beginning of period | 35.79 Million | 31.16 Million | 51.81 Million | 73.98 Million | 49.98 Million | 83.39 Million |
| Cash at end of period | 28.84 Million | 35.79 Million | 31.16 Million | 31.16 Million | 51.81 Million | 49.98 Million |
| Capital Expenditure | -3.05 | - | - | - | - | - |
| Effect of forex changes on cash | -34 Thousand | -246 Thousand | 568 Thousand | 455 Thousand | -229 Thousand | -19 Thousand |
| Net cash flow / Change in cash | -6.94 Million | 4.62 Million | -20.64 Million | -42.81 Million | 1.82 Million | -33.4 Million |
| Free Cash Flow | -17.99 Million | -29.7 Million | -28.02 Million | -132.86 Million | -38.22 Million | -32.02 Million |
7936
6728
NAKSH
ACCR
TERASOFT
VGID